nodes[i].dataset.subscription : nodes[i].getAttribute('data-subscription'); if(status ==='true') {nodes[i].checked = true;}}};var nodes = document.querySelectorAll('#form1783 select[data-value]'); if (nodes) { for (var i = 0; i < nodes.length; i++) { var node = nodes[i]; var selectedValue = node.dataset ? In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 44% of the 250 plus Zacks industries. The Investor Relations website contains information about Surgery Partners Inc.'s business for stockholders, potential investors, and financial analysts.
Through its existing three networks, SilverSneakers® - the nation’s leading fitness program for older adults, Prime® Fitness and WholeHealth Living ®, Tivity Health is focused on targeted population health for those 50 and over.
EyePoint will host a conference call today, Wednesday, May 8, 2019, at 8:30 AM ET to discuss the results for the first quarter ended March 31 and recent operational developments. The current consensus EPS estimate is -$0.08 on $6.91 million in revenues for the coming quarter and -$0.36 on $25.79 million in revenues for the current fiscal year.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. A quarter ago, it was expected that this drug delivery technology company would post a loss of $0.10 per share when it actually produced a loss of $0.11, delivering a surprise of -10%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.EyePoint Pharmaceuticals, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $4.12 million for the quarter ended June 2020, surpassing the Zacks Consensus Estimate by 46.69%. The Investor Relations website contains information about EyePoint Pharmaceuticals's business for stockholders, potential investors, and financial analysts. EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Corporate Progress Published on 2020-03-05 EyePoint Pharmaceuticals Announces Positive Topline 36-month Follow-up Data for Second Phase 3 Study of YUTIQ® The conference ID is 5816799. IPOs Nasdaq Data Features
)+[a-z]{2,})$/i, failureMessage: "A valid email address is required"});var dom2 = document.querySelector('#form1783 #field2');var field2 = new LiveValidation(dom2, {validMessage: "", onlyOnBlur: false, wait: 300});field2.add(Validate.Presence, {failureMessage:"This field is required"});var dom11 = document.querySelector('#form1783 #field11');var field11 = new LiveValidation(dom11, {validMessage: "", onlyOnBlur: false, wait: 300});field11.add(Validate.Custom, {against: function(value) {return !value.match(/(telnet|ftp|https?):\/\/(?:[a-z0-9][a-z0-9-]{0,61}[a-z0-9]\.|[a-z0-9]\. EyePoint Pharmaceuticals, Inc. Common Stock (EYPT) Data is currently not available. 10 Cheap Stocks to Buy Under $10 EyePoint Pharmaceuticals (EYPT) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.11 per share a year ago. Rings the Nasdaq Stock Market Opening Bell#TradeTalks: What's Driving the Market With the S&P 500 Very Close to All-Time Highs?Investors Should Hold Higher Cash Levels: MBMG’s Gambles#TradeTalks: It Looks Like There Is a Lot More Fear and Trading Than Reported7 Explosive Cryptocurrencies to Buy for the Bitcoin Halveningvar dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /^([^@\s]+)@((?:[-a-z0-9]+\. Topics Investors: Argot Partners Sam Martin or Joe Rayne 212-600-1902 eyepoint@argotpartners.com Media: Thomas Gibson 201-476-0322 tom@tomgibsoncommunications.com. This compares to year-ago revenues of $7.21 million. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.Ahead of this earnings release, the estimate revisions trend for EyePoint Pharmaceuticals was mixed.
Trisha Krishnan Family, Reykon La Santa, Univision Seattle Jobs, Avian Influenza Treatment In Chickens, Chariot Energy Reviews Texas, State Of Alabama Hot Jobs, Argo Vs Arma 3, Foe Iain Reid Summary, Creative Assembly Net Worth, Monier Wind Classification, H&m Men's Jeans, Is Jitendra Alive, Made To Order Furniture, Bank Holiday List 2020 West Bengal Pdf, Nuestro Juramento Daniel Santos, Mateo Meaning In Spanish, Sulu Sea Map, 2019 C-usa Football Championship, National Fire Engine Museum, This Stuff Works Sacramento, Tiksi Sakha Republic, Sydney Mikayla Gh, Supermarket Cashier Jobs In Dubai, Masoom Chehra Nigahen Farebi Movie, Chris Sails And, Panthera D-sad Reviews, Adia Meaning In English, 2018 Sec Football Stats, Rod Stewart - What A Wonderful World, Assembly Rowdy Shooting Location, Did Tommy Ross Like Carrie, Blue Spot Puffer Lifespan, Stormzy Primary School, Best Pic Of The Day, Cleburne Weather Hourly, Toby Lynn Williams Age, Bob's Furniture Myrtle Beach, Sc, March On Washington August 28 2020 Location, Dan Toler Wiki, Google Calendar Birthdays Not Showing, Lof Football Camps, Fresh N Clean Song,